Large granular lymphocyte proliferative disease: 21 Belgian cases and review of the literature. 1992

P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
Hôpital de Jolimont, La Louvière, Bruxelles.

We report the findings in 21 Belgian patients (12 males and 9 females, median age 61 years) with LGLPD. Symptoms at presentation included infection (n = 9), weight loss (n = 5), asthenia (n = 9), pruritus (n = 2) and arthralgia (n = 7). Four patients were asymptomatic. The main clinical findings were hepatomegaly (n = 5), splenomegaly (n = 8), lymph node enlargement (n = 3) and arthritis (n = 5). All patients had an increased LGL count associated with anemia (n = 12), neutropenia (n = 17), often less than 0.5.10(9)/L (n = 10) and thrombocytopenia (n = 6). Three patterns of lymphocyte surface markers were observed: CD3+CD4-8+ (14 patients), CD3+CD4-8+ (5 patients) and CD3+CD4+8- (1 patient). An abnormal karyotype was found in 2 patients. T-cell receptor gene was rearranged in all cases tested (9/9).

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
October 1988, Leukemia,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
September 1987, Medicine,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
August 1986, Scandinavian journal of haematology,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
January 2000, Ryoikibetsu shokogun shirizu,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
March 2002, British journal of haematology,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
October 1988, American journal of hematology,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
June 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
January 1989, Haematologica,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
October 1994, British journal of haematology,
P G Pierre, and A Bosly, and R De Bock, and L Debusscher, and A Ferrant, and W Feremans, and P Lacor, and J L Michaux, and B Van Camp, and A Van Hoof
June 1994, Annals of hematology,
Copied contents to your clipboard!